Auna SA Hits New 52-Week Low at USD 4.17 Amid Decline

Auna SA, a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 4.17 on May 22, 2026. This significant decline highlights the stock's ongoing struggles, as it has experienced a return of -32.03% over the past year, contrasting sharply with the S&P 500's performance of 27.93% during the same period. With a market capitalization of USD 383 million, Auna SA's financial metrics reveal a P/E ratio of 7.00, indicating a low valuation relative to earnings. However, the company faces challenges, as evidenced by its return on equity, which is notably negative. The stock's price-to-book ratio stands at 0.80, suggesting that it is trading below its book value. Despite a lack of dividend yield and a debt-to-equity ratio of 1.95, Auna SA's recent performance underscores a trend of underperformance both in the near term and over the long term. Investors will be closely monitoring the company's ability to navigate these financial hurdles as it continues to operate in a competitive industry.